Table 4 Multivariate Cox regression analysis for all-cause mortality associated with UACR and UNAPCR mutually adjusted.
HR (95%CI) | p value | |
|---|---|---|
UACR ≥ 30 mg/g | 1.046 (0.820–1.334) | 0.717 |
UNAPCR ≥ 120 mg/g | 1.655 (1.324–2.070) | < 0.001 |
Age (year) | 1.058 (1.049–1.066) | < 0.001 |
Hypertension (yes vs. no) | 0.744 (0.458–1.208) | 0.231 |
CVD (yes vs. no) | 1.333 (0.940–1.890) | 0.106 |
Cancer (yes vs. no) | 1.431 (1.224–1.674) | < 0.001 |
Glomerular disease (yes vs. no) | 1.439 (1.191–1.739) | < 0.001 |
BMI ≥ 24 (kg/m2) | 0.801 (0.684–0.938) | 0.006 |
HbA1c (%) | 1.088 (1.044–1.133) | < 0.001 |
CKD* (yes vs. no) | 1.426 (1.182–1.720) | < 0.001 |
Triglycerides ≥ 1.7 (mmol/L) | 0.956 (0.815–1.123) | 0.587 |
GPT (U/L) | 1.002 (0.999–1.005) | 0.175 |
Hb (g/L) | 0.891 (0.855–0.929) | < 0.001 |
Statin use (yes vs. no) | 0.811 (0.694–0.947) | 0.008 |
DPP-4 inhibitor use (yes vs. no) | 0.782 (0.671–0.913) | 0.002 |
RAS blockade use (yes vs. no) | 1.189 (1.014–1.395) | 0.033 |
Insulin use (yes vs. no) | 1.372 (1.160–1.624) | < 0.001 |